ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

$NPCE:NASDAQ · Neuropace Inc - US

NeuroPace — responsive epilepsy neurostimulation

Sector: health

Conviction from: NASDAQCitrini

52-week range: 5.4619.60

2 tracked filer(s) hold this · 1 opened, 1 added, 0 trimmed in 30-SEP-2026

Aggregate 13FScore 68 — mean of 2 scored holder(s) · buyers (new/add) avg 68. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Steve Cohen / Point7275New buy28,843$396,8800.0%
Paul Tudor Jones / Tudor61Added +30%143,233$1,970,8860.0%

Beyond 13F — activists, insiders, politicians & research

Citrini Research coverage report library →

ReportDateStance
#80 — Market Memo: January Musings2025-01-09LONG

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.